Aclaris Therapeutics ACRS
$3.44 −$0.06 (-1.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.44 0.00%
Open$3.44
Prev close$3.50
Day range$3.40 – $3.55
Volume2.19M
Market cap$545.63M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts7
Average target$11.71+240.4% vs. price
- Buy 100%
Low $8.00Now $3.44Avg $11.71High $16.00
Recent rating changes
The last 20 actions on file set price targets from $8.00 to $16.00, averaging $12.25.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | H.C. Wainwright | BUY | $16.00 |
| 6 Nov 2026 | CCORF | BUY | $13.00 |
| 6 Nov 2026 | Wedbush | BUY | $8.00 |
| 30 Oct 2026 | CCORF | BUY | $13.00 |
| 28 Oct 2026 | Craig-Hallum | BUY | $9.00 |
| 28 Oct 2026 | Guggenheim | BUY | $12.00 |
| 28 Oct 2026 | H.C. Wainwright | BUY | $16.00 |
| 19 Oct 2026 | Piper Sandler | BUY | $11.00 |
| 7 Oct 2026 | Piper Sandler | BUY | $11.00 |
| 1 Oct 2026 | LifeSci Capital | BUY | $13.00 |
| 1 Sep 2026 | CCORF | BUY | $10.00 |
| 31 Aug 2026 | Piper Sandler | BUY | $11.00 |
| 10 Aug 2026 | H.C. Wainwright | BUY | $16.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $11.00 |
| 6 Aug 2026 | LifeSci Capital | BUY | $13.00 |
| 6 Aug 2026 | Craig-Hallum | BUY | $10.00 |
| 17 Jul 2026 | Piper Sandler | BUY | $11.00 |
| 1 Jun 2026 | LifeSci Capital | BUY | $13.00 |
| 11 May 2026 | Guggenheim | BUY | $12.00 |
| 11 May 2026 | H.C. Wainwright | BUY | $16.00 |
No comments yet — be the first to weigh in on ACRS.
Sign in to join the discussion.